Navigation Links
Movement in Medical Technology

Merz Pharmaceuticals Announce Three Studies of NT-201 - (Botulinum neurotoxin type A Free From Complexing Proteins)

... represent the second data set presented at the movement Disorder Society (MDS) 13th Annual International ... future. The NT-201 data presented at the movement Disorder Society's annual meeting includes the ... Europe, may be a new option in the treatment of movement disorders in the United States." First ...

Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ)

... Calif., May 18 /PRNewswire/ -- The Feldenkrais movement Institute announces the release of The ... of its The Intelligent Body(R) DIY-series of movement reeducation lessons available on CD. The program ... back. The lessons also reverse long-standing movement habits often responsible for the original TMJ ...

Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients

... in Europe) for the symptomatic management of movement disorders," said Eric Pappert, M.D., Vice ... marketing in Europe since 2007 to treat various movement disorders, and recently approved in Canada for ... -- potentially offers a new option to treat movement disorders. Because Xeomin combines high biologic ...

Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease

... to report on the results of this trial at the movement Disorder Society's 13th International Congress of Parkinson's Disease and movement Disorders in Paris in June 2009. The company ... represent a novel choice in the treatment of movement disorders without some of the complications of ...

Omeros and The Parkinson's Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders

... proprietary to Omeros, for the treatment of movement disorders. The collaboration is based on Omeros' ... to establish a link between our target and any movement disorder," stated Gregory A. Demopulos, M.D., ... with Parkinson's disease, RLS and other movement disorders. About Omeros Corporation Omeros ...

Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results

... in complete spontaneous bowel movement (CSBM) frequency, stool consistency, straining, ... assessed. Glossary of Terms Spontaneous bowel movement (SBM): An SBM is a bowel movement that occurs in the absence of laxative, enema, or ...

Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies

... pre-treatment in weekly spontaneous bowel movement (SBM) frequency rate. During the two-week ... efficacy endpoints-complete spontaneous bowel movement (CSBM) frequency, stool consistency, straining, ... Glossary of Terms Spontaneous bowel movement (SBM): An SBM is a ...

Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting

... trial and one upper limb spasticity trial -- were presented at the movement Disorder Society (MDS) 13th annual International Congress in Paris, ... It has been approved for marketing in Europe since 2007 to treat various movement disorders, and more recently approved in Canada for the indications of ...

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

... full list of SAC members can be found at www.su2c.org.] SU2C As a movement "Stand Up To Cancer grew from two simple constructs: scientists ... the Stand Up To Cancer Initiative The Stand Up To Cancer (SU2C) movement raises funds to hasten the pace of groundbreaking translational research ...

BIOCOM's 4th Annual DeviceFest Honors Companies

... received the "Life Changing" award for its device designed to improve movement to individuals who are unable to maintain the body's movement through natural means. "DeviceFest is a great event for medical ...

Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial

... and speech. Parkinson's disease belongs to a group of conditions called movement disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement (bradykinesia) and, in extreme cases, a loss of physical movement (akinesia). The primary symptoms are the results of decreased stimulation ...

Michael J. Fox Foundation Awards $2.9 Million for Two New Parkinson's Disease Clinical Trials

... PhD, Universiy of Bordeaux, France, and Francois Tison, MD, PhD, Head of movement Disorder Unit, University Hospital of Bordeaux, France A Pilot ... Early Parkinson's Disease Tanya Simuni, MD, Parkinson's Disease and movement Disorders Center, Northwestern University About The Michael J. Fox ...

U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease

... can be problematic for these patients, causing simple activities and movement to become difficult. Results from a pivotal efficacy and safety trial ... tremor (involuntary shaking), rigidity (stiffness), akinesia (lack of movement or loss of spontaneous movement), bradykinesia (slower-than-normal ...

New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study

... end points were the proportion of patients with a rescue-free bowel movement within four hours of the first dose, and the proportion of patients with ... phase of the study, 48 percent of patients experienced a bowel movement within four hours of receiving the first dose of RELISTOR (0.15 mg/kg), ...

Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis

... motor neurons die, the ability of the brain to initiate and control muscle movement is lost. With voluntary muscle movement action progressively negatively affected, those patients in the later ...

Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease

... 2007. About Parkinson's Disease Parkinson's disease is a progressive movement disorder that affects at least one million people in the United States. It ... of the midbrain. Dopamine is a neurotransmitter involved in controlling movement and coordination, so Parkinson's patients exhibit the progressive ...

PET Scans Show Gene Therapy Normalizes Brain Function in Parkinson's Patients

... the viral vector-carrying genes to the side of the brain that controls movement on the side of their body most affected by the disease. It was a so-called ... they identified two discrete brain networks -- one that regulates movement and another that affects cognition. The results from the brain scan study ...

Mayo Clinic Physicians Report Findings from Research on Sleep Disorders

... during sleep when the throat muscles relax People with the rapid eye movement (REM) sleep disorder known as REM behavior disorder (RBD) sometimes act ... episodes occur when the muscle paralysis normally present during rapid eye movement (REM) sleep is incomplete or absent, allowing the person to physically act ...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

... we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new ...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

... we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new ...

Pennsylvania Agriculture Department Issues Quarantine for Allegheny County Horse Stable

... causes upper respiratory infection and can cause severe neurological disease in horses," said Wolff. "The quarantine was put in place to restrict the movement of horses from the stable and contain the virus." The quarantine covers the entire property, including five barns housing more than 100 ....

Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases

... we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new ...

June 2009 Mayo Clinic Women's HealthSource Highlights Summer Skin Problems, Low Vision and Pilates

... repetitions. The best way to start is to enroll in a class taught by a qualified instructor. Success with Pilates depends on precision of movement and effort. Proper instruction is key to knowing how to exercise and achieve the benefits. Mayo Clinic Women's HealthSource is published ...

Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases

... to a review in the June 2009 issue of Mayo Clinic Proceedings . "Deep brain stimulation has long been seen as valuable for controlling movement disorders," according to the review, written by Susannah Tye, Ph.D., Mark Frye, M.D. , from the Mayo Clinic Department of Psychiatry and ...

Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients

... and swelling, ultimately leading to irreversible joint destruction and disability. Characteristics of RA include redness, swelling, pain and movement limitation around joints of the hands, feet, elbows, knees and neck that leads to loss of function. In addition, the systemic symptoms of RA include ...

Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

... and dose response of linaclotide in patients with IBS-C. The primary efficacy endpoint was change from baseline in complete spontaneous bowel movement (CSBM) frequency. The study evaluated the effects of 75, 150, 300, or 600 ug linaclotide or placebo administered orally once daily to adults meeting ...

VA Studies Advanced Prosthetic Arm

... to work with other control systems, including myoelectric switches, which are wired to residual nerves and muscles in the upper body and respond to movement impulses from the brain, shoulder joysticks or other conventional inputs. Frederick Downs Jr., director of VA's Prosthetic and Sensory Aids ...

Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients

... and swelling, ultimately leading to irreversible joint destruction and disability. Characteristics of RA include redness, swelling, pain and movement limitation around joints of the hands, feet, elbows, knees and neck that leads to loss of function. In addition, the systemic symptoms of RA include ...

Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia

... were statistically analyzed using a mixed model for repeated measures. Multiple safety assessments were done, including vital signs, weight, ECGs, movement disorder scales (SAS, BAS, AIMS), and laboratory assessments. The study was conducted at 51 sites worldwide. Twenty-two sites in the United ...

RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder

... CONSTA(R). Call your doctor immediately if you think you are having this problem. Extrapyramidal Symptoms (EPS) are usually persistent movement disorders or muscle disturbances, such as restlessness, tremors, and muscle stiffness. If you observe any of these symptoms, talk to your healthcare ...

New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting

... a treatment regimen that suits their individual needs," stated Robert Hauser, MD, Professor of Neurology, and Director, Parkinson's Disease & movement Disorders Center at the University of South Florida College of Medicine, and a co-author on both studies. "These data suggest that this potential ...

Michael J. Fox Foundation Awards $2.1 Million to Improve Drug Delivery in Parkinson's Disease

... the Distribution of Therapeutic Agents In Vivo RamakrishnaVenugopalan, Ph.D., Codman and Shurtleff, Inc. Deep Brain Imaging to Determine the movement of Compounds Relevant to Parkinson's Disease Mark Saltzman, Ph.D., and Michael Levene, Ph.D., Yale University Novel Antibodies for the ...

Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients

... have worked together to provide recommendations for treatment of inpatient hyperglycemia, and these efforts have contributed to a growing national movement viewing the management of hyperglycemia in hospitals as a quality care measure," Dr. Etie S. Moghissi, AACE Chair of Inpatient Glycemic Control Task ...

The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent

... in Auckland, New Zealand and principal investigator in the first phase of the ABSORB trial. "With no rigid stent remaining, vasomotion - the natural movement of the artery - was restored, and the artery appeared to behave like a normal artery. Who would want a permanent device if a temporary one may do the ...

March 2009 Mayo Clinic Health Letter Highlights Knee Repair Surgery, Anxiety Disorder and Preventing Blood Clots

... The ACL is a key ligament that stabilizes and supports the knee joint. It connects the thigh bone (femur) to the shinbone (tibia) and controls movement of the lower leg. The ACL is an important knee stabilizer when twisting, pivoting or jumping. On the tennis court or during other ...

CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth

... guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes ...

Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial

... projects. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new ...

Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

... we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new ...

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)

... had seizures in the past, or who have conditions that increase their risk for seizures. Extrapyramidal Symptoms (EPS) are usually persistent movement disorders or muscle disturbances, such as restlessness, tremors, and muscle stiffness. If you observe any of these symptoms, talk to your healthcare ...

Heavy Marijuana Use May Damage Developing Brain in Teens, Young Adults

... using the drug. The study team performed a type of magnetic resonance imaging scan called diffusion tensor imaging (DTI) that measures water movement through brain tissues. "The abnormal patterns of water diffusion that we found among the young men with histories of marijuana use suggest damage or ...
Other Contents
(Date:7/23/2014)... the world by 2050, according to one of the ... (IPCC), may be advantageous to the physiology and the ... forage plants such as Stylosanthes capitata Vogel , ... such as Brazil., The conclusion is from a study ... at the Ribeiro Preto Faculty of Philosophy, Sciences and ...
(Date:7/23/2014)... MA -- What do mollusks, starfish, and corals ... habitat, they are all calcifiersorganisms that use calcium ... and shells for stability and protection. , The ... published by the Marine Biological Laboratory, addresses the ... changes worldwide. , As atmospheric carbon dioxide rises, ...
(Date:7/23/2014)... MINNETONKA, Minn. , July 23, 2014 /PRNewswire/ ... technology company specializing in clinical study management systems, ... West , a proven life sciences industry executive ... named Chief Operating Officer (COO).  Clareece will be ... and sales growth, operational efficiency and quality product/service ...
Breaking Biology News(10 mins):An increase in temperature by 2050 may be advantageous to the growth of forage plants 2An increase in temperature by 2050 may be advantageous to the growth of forage plants 3An increase in temperature by 2050 may be advantageous to the growth of forage plants 4Calcification in changing oceans explored in special issue of The Biological Bulletin 2MedNet Appoints Clareece West As Chief Operating Officer 2
(Date:7/23/2014)... Alan Mozes HealthDay Reporter ... more likely to have been exposed to some form of ... suggests. The finding seems to apply solely to military ... finding could be a cause for concern, given that early ... abuse among the civilian population has been linked to a ...
(Date:7/23/2014)... Colo. (PRWEB) July 23, 2014 The ... a woman from Milwaukee, Wis. who was physically fit ... age 21, she ultimately made the heart-wrenching decision to ... haunted her for the past 18 years, and she ... the process. , Featuring a unique, non-competitive approach to ...
(Date:7/23/2014)... 23, 2014 (HealthDay News) -- Regularly checking the pulse ... researchers report. "Screening pulse is the method of ... age 65 who have never had a stroke. Our ... and easy way to identify people who might need ... study author Dr. Bernd Kallmunzer, of Erlangen University in ...
(Date:7/23/2014)... DC (PRWEB) July 23, 2014 ... for ATA 2015, ATA’s twentieth annual meeting and ... The meeting, expected to attract over 5,000 attendees ... will take place May 3-5, 2015, in Los ... most renowned healthcare technology professionals from researchers, clinicians, ...
(Date:7/23/2014)... disorders of obesity and dementia reside in the brain, ... Behavioral Neuroscience. In the paper, researchers make the case ... the brain responsible for memory and learning. Furthermore, treatments ... in reducing certain dementias., "In the struggle to treat ... This is a new way for providers who treat ...
Breaking Medicine News(10 mins):Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 2Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 3Health News:“Extreme Weight Loss”: Cassie’s journey begins at the University of Colorado Anschutz Health and Wellness Center 2Health News:Routine Pulse Check May Prevent Second Stroke, Study Says 2Health News:ATA Seeks Speakers to Present at the World’s Largest Telemedicine, mHealth and Telehealth Conference 2Health News:Targeting the brain to treat obesity 2Health News:Targeting the brain to treat obesity 3
Other TagsOther Tags